A carregar...
miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
The multidrug resistance (MDR) acquired in human osteosarcoma is a huge obstacle for effective chemotherapy. Recently, microRNA-26a (miR-26a) has been associated with the pathogenesis and progression of osteosarcoma. However, whether it regulates MDR in osteosarcoma is unknown. We show here that miR...
Na minha lista:
| Publicado no: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8012539/ https://ncbi.nlm.nih.gov/pubmed/33816494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.645381 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|